Skip to main content
Premium Trial:

Request an Annual Quote

Lee Bendekgey, Vladimir Vapnik, Ken Welsh

Premium

Lee Bendekgey has joined Nuvelo as senior vice president and general counsel. Bendekgey was previously at Incyte, where he held several executive positions, including executive vice president, general counsel, acting chief financial officer, and acting general manager of the company’s information business. Prior to Incyte, Bendekgey worked for Silicon Graphics, where he held a variety of positions in SGI’s legal group.


Health Discovery Corporation, a systems biology-based biomarker discovery company, has appointed Vladimir Vapnik and Ken Welsh to its scientific advisory board. Vapnik led the machine learning research department at the Institute of Control Sciences in Moscow, where he worked from 1965 to 1990. In the US, he worked at AT&T Bell Laboratories. Welsh is currently a professor of clinical genomics at Royal Brompton Hospital and a scientific advisor to the West London Transplant Center.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more